Australia's EBR Systems heads for worst week in nearly two months after US FDA risk assessment
11/09/2026 06:17
BUZZ-Australia's EBR Systems heads for worst week in nearly two months after US FDA risk assessment ** Shares of Australia's EBR Systems EBR.AX on track for a weekly loss of about 7.1%, their worst weekly performance in nearly two months
** In current session, stock down as much as 5.5% to A$0.260, hitting lowest level since August 3
** Earlier this week, the wireless cardiac pacing system provider said the U.S. Food and Drug Administration classified a cybersecurity incident as "Controlled Risk"
** The company disclosed in February that a cybersecurity breach resulted in unauthorized access to personal information
** EBR said it has implemented cybersecurity enhancements and system-hardening measures to mitigate future risks
** YTD, stock down 69%
(Reporting by Paridhi Minda in Bengaluru)
Recent news on EBR Systems
See all newsAustralia's EBR Systems jumps on filing application for heart treatment
Brief: EBR Systems Submits TGA ARTG Application For Wise® System
Australia's EBR Systems hits record low on weak third-quarter revenue outlook
Brief: EBR Systems Forecasts Q3 2026 Revenue Of US$2.4 MLN To US$2.5 MLN
Brief: EBR Systems Announces Its Plan To Submit A Changes For Supplements To FDA In Q4 2026